Showing results (191-200 of 466) with videos related to
Sort By:
Pageof 47
British Journal of Biomedical Science|April 27, 2013
The FUS1 gene inhibits EC109 cell growth mediated by a lentivirus vectorB Zhang, X Xu, Z Qi, et al.International Journal of Cancer|June 22, 2000
A novel approach for inducing enhanced and selective transgene expression in hepatocellular-carcinoma cellsG Cao, S Kuriyama, H Tsujinoue, et al.International Urology and Nephrology|November 25, 2017
Preoperative urine culture is unnecessary in asymptomatic men prior to prostate needle biopsyDavid Z Qi, Kathleen Lehman, Kalyan Dewan, et al.The Journal of Antibiotics|April 1, 1984
A new naphthaquinone antibiotic from a new species of yeastT W Flegel, V Meevootisom, Y Thebtaranonth, et al.The Journal of Biological Chemistry|January 27, 1998
Association of neurofilament proteins with neuronal Cdk5 activatorZ Qi, D Tang, X Zhu, et al.Journal of Medical Economics|May 14, 2020
Estimation of total costs in patients with relapsed or refractory diffuse large B-cell lymphoma receiving tisagenlecleucel from a US hospital's perspectiveHongbo Yang, Yanni Hao, Xinglei Chai, et al.Scientia Sinica. Series B, Chemical, Biological, Agricultural, Medical & Earth Sciences|March 1, 1982
Complete amino acid sequence of mung bean trypsin inhibitorY Zhang, S Luo, F Tan, et al.FEBS Letters|March 12, 2004
Alpha-chimaerin exists in a functional complex with the Cdk5 kinase in brainRobert Z Qi, Yick-Pang Ching, Hsiang-Fu Kung, et al.The Journal of Biological Chemistry|November 25, 2003
Direct regulation of microtubule dynamics by protein kinase CK2Anthony C B Lim, Sock-Yeen Tiu, Qing Li, et al.Clinical Therapeutics|August 12, 2021
Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United StatesCynthia Z Qi, Vamsi Bollu, Hongbo Yang, et al.Pageof 47